Contributions
Abstract: EP1392
Type: Poster Sessions
Abstract Category: Clinical aspects of MS - MS symptoms
Introduction: Multiple sclerosis (MS) is an inflammatory autoimmune disease, a degenerative disorder of the central nervous system. In the literature, there are few original studies on sleep disorders and MS that rely on small groups of patients.
Objectives: To evaluate the prevalence of sleep disorders
Identify the most common disorders
Patients and methods: Our study is prospective .The data collected: demographic, clinical form, current disability appreciated by EDSS, current treatment (interferon) .The Epworth Sleepiness Scale Sleep Scale (ESS) was used to assess daytime sleepiness. .A questionnaire: for nocturnal sleep disorders
* 1st component: appreciated the difficulties to fall asleep (initial insomnia), waking up during the night (average insomnia), nightmares and behavioral problems during sleep, waking up early in the morning without falling asleep again (terminal insomnia)
* the second part included the symptoms of MS that affect sleep
Patients excluded from the study are those who are undergoing treatment or who are taking corticosteroid
Results: 254 patient patients were included in the study. Prevalence sleep disorders 52.7% .Avoid night-time sleep disorders terminal insomnia is more common (50.7%), followed by average insomnia (33%) and initial insomnia (28%) Epworth sleeping scale (ESS) sleep results of less than 8 in 84%, between 9 and 15 in 15%, greater than 15 in 0.7% Table III: No relationship between demographic variables The signs of MS that influenced sleep were pain (21%), spasticity (18%), and bladder disorders (11%).
Discussion: More than 50% of our patients complained of sleep disorders, a result similar to the data from the literature.
-The results of the Epworth Scale, lower and higher values have been noted by other authors.We did not find any relationship between sleep disorders and demographic factors. Some authors have suggested a higher prevalence among women.
-On our patients, sleep disorders did not depend on disability or clinical form.The majority of authors have not found such relationships. Signs of MS that influenced sleep are consistent with other studies. We found a lower prevalence of NST in patients treated with interferons. These problems are described among the side effects of the treatment.
Conclusion: Sleep disorders are a serious problem and deserve more attention in patients with MS. Polysomnography would be important to detect these long-unknown disorders
Disclosure: nothing to disclose
Abstract: EP1392
Type: Poster Sessions
Abstract Category: Clinical aspects of MS - MS symptoms
Introduction: Multiple sclerosis (MS) is an inflammatory autoimmune disease, a degenerative disorder of the central nervous system. In the literature, there are few original studies on sleep disorders and MS that rely on small groups of patients.
Objectives: To evaluate the prevalence of sleep disorders
Identify the most common disorders
Patients and methods: Our study is prospective .The data collected: demographic, clinical form, current disability appreciated by EDSS, current treatment (interferon) .The Epworth Sleepiness Scale Sleep Scale (ESS) was used to assess daytime sleepiness. .A questionnaire: for nocturnal sleep disorders
* 1st component: appreciated the difficulties to fall asleep (initial insomnia), waking up during the night (average insomnia), nightmares and behavioral problems during sleep, waking up early in the morning without falling asleep again (terminal insomnia)
* the second part included the symptoms of MS that affect sleep
Patients excluded from the study are those who are undergoing treatment or who are taking corticosteroid
Results: 254 patient patients were included in the study. Prevalence sleep disorders 52.7% .Avoid night-time sleep disorders terminal insomnia is more common (50.7%), followed by average insomnia (33%) and initial insomnia (28%) Epworth sleeping scale (ESS) sleep results of less than 8 in 84%, between 9 and 15 in 15%, greater than 15 in 0.7% Table III: No relationship between demographic variables The signs of MS that influenced sleep were pain (21%), spasticity (18%), and bladder disorders (11%).
Discussion: More than 50% of our patients complained of sleep disorders, a result similar to the data from the literature.
-The results of the Epworth Scale, lower and higher values have been noted by other authors.We did not find any relationship between sleep disorders and demographic factors. Some authors have suggested a higher prevalence among women.
-On our patients, sleep disorders did not depend on disability or clinical form.The majority of authors have not found such relationships. Signs of MS that influenced sleep are consistent with other studies. We found a lower prevalence of NST in patients treated with interferons. These problems are described among the side effects of the treatment.
Conclusion: Sleep disorders are a serious problem and deserve more attention in patients with MS. Polysomnography would be important to detect these long-unknown disorders
Disclosure: nothing to disclose